LEADER 01633nas  2200529-a 450 
001 996476372703316
005 20230330000911.0
011   $a2040-2058
035   $a(DE-599)ZDB2118396-X
035   $a(CKB)954925619137
035   $a(CONSER)sn-99039880-
035   $a(EXLCZ)99954925619137
100   $a19981016a19969999  ---            -
101 0 $aeng
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 00$aAntiviral therapy$b[electronic resource]
210   $aLondon $cInternational Medical Press
210 31$a[London] :$cSAGE Publications
215   $a1 online resource
300   $aRefereed/Peer-reviewed
311 08$aPrint version: Antiviral therapy. 1359-6535 (DLC)sn 99039880 (OCoLC)42889502 
531   $aANTIVIR THER
531   $aANTIVIR TH
531   $aANTIVIR. THER. (LOND.)
531   $aANTIVIR. THER
606   $aAntiviral agents$vPeriodicals
606   $aAntiviral agents$2fast$3(OCoLC)fst00810869
606   $aAntiviral Agents$xtherapeutic use
606   $aVirus Diseases$xtherapy
606   $aViruses$xdrug effects
608   $aPeriodicals.$2fast
608   $aPeriodicals.
610 1 $aAntivirals
615  0$aAntiviral agents
615  7$aAntiviral agents.
615 12$aAntiviral Agents$xtherapeutic use.
615 22$aVirus Diseases$xtherapy.
615 22$aViruses$xdrug effects.
676   $a616.92506
712 02$aInternational Society for Antiviral Research.
906   $aJOURNAL
912   $a996476372703316
920   $aexl_impl conversion
996   $aAntiviral therapy$92566835
997   $aUNISA